Related Experiment Video
Updated: Apr 4, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Cardiovascular complications in chronic active Epstein-Barr virus infection: a narrative review
Jing Xu1, Yunfeng Wei1, Lin Shi2
1Department of Ultrasound, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
Insights
Cardiovascular complications from chronic active Epstein-Barr virus (CAEBV) infection are rare but serious. This review summarizes patient data to improve understanding and management of these cardiac issues.
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- Cardiovascular involvement in chronic active Epstein-Barr virus (CAEBV) infection is an uncommon but severe complication.
- Existing data on managing CAEBV-associated cardiovascular damage is limited.
- This review addresses the need for comprehensive information on CAEBV's cardiac impact.
Purpose of the Study:
- To summarize clinical characteristics, pathological features, diagnostic approaches, and treatment strategies for CAEBV-related cardiac damage.
- To enhance awareness of cardiovascular complications associated with CAEBV infection.
- To provide insights for clinical management of these rare conditions.
Main Methods:
- A narrative review was conducted.
- Searched PubMed, Embase, Web of Science, CNKI, CQVIP, and Wanfang Data databases.
- Collected data on CAEBV infection with cardiovascular involvement.
Main Results:
- 32 articles reporting 57 patients with CAEBV-associated cardiovascular complications were identified.
- Median age was 11 years, with 66.7% children and 33.3% adults.
- Coronary artery lesions, arrhythmias, and valvular issues were common in children; heart failure and pulmonary hypertension were more prevalent in adults.
Conclusions:
- Cardiovascular involvement in CAEBV infection poses significant diagnostic and therapeutic challenges.
- Systematic evaluation is crucial for timely intervention and surveillance.
- Further research is needed to understand pathogenic mechanisms and optimize treatment due to poor prognosis.
Background:
Cardiovascular involvement in chronic active Epstein-Barr virus (CAEBV) infection represents an uncommon yet severe spectrum of complications, including coronary artery lesions, arrhythmias, and pulmonary arterial hypertension. Reliable large-scale data for the management of CAEBV-associated cardiovascular damage are currently lacking. In this literature review, we aimed to summarize the clinical characteristics, pathological features, diagnostic approaches, and treatment strategies for CAEBV-related cardiac damage. This summary may enhance the awareness of CAEBV-associated cardiovascular complications and provide valuable insights for their clinical management. In this narrative review, we aimed to summarize the clinical characteristics, pathological features, diagnostic approaches, and treatment strategies for CAEBV-related cardiac damage.
Methods:
PubMed, Embase, Web of Science, CNKI, CQVIP, and Wanfang Data databases were searched as part of this narrative review to collect data on CAEBV infection with cardiovascular involvement and to summarize its characteristics, pathological features, diagnostic approaches, and treatment strategies.
Results:
We identified 32 articles reporting CAEBV-associated cardiovascular complications involving 57 patients with a median age of 11 years (range: 1-69 years). Among these patients, 19 (33.3%) were adults and 38 (66.7%) were children; 24 (42.1%) were male and 33 (57.9%) were female. Coronary artery lesions, electrocardiographic abnormalities, valvular regurgitation, and pericardial lesions were more frequent in children, whereas heart failure and pulmonary arterial hypertension were more prevalent in adults.
Conclusions:
Cardiovascular involvement in CAEBV infection is rare and presents substantial diagnostic and therapeutic challenges. The systematic evaluation of cardiovascular involvement is crucial for timely intervention and long-term surveillance. The poor prognosis of CAEBV-associated cardiovascular complications underscores the urgent need for further research to elucidate its pathogenic mechanisms and optimize therapeutic strategies.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis IV: Nursing Management

